CytoAgents, Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of CTO1681 for the Prevention and Treatment of CRS in DLBCL Patients Receiving CAR T-Cell Therapy (NCT05905328) | CytoAgents, Inc. | 2023-12-28 |
Track CytoAgents, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.